Cargando…
Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
Lung cancer is the deadliest cancer worldwide, mainly due to its advanced stage at the time of diagnosis. A non-invasive method for its early detection remains mandatory to improve patients’ survival. Plasma levels of 351 proteins were quantified by Liquid Chromatography-Parallel Reaction Monitoring...
Autores principales: | El-Khoury, Victoria, Schritz, Anna, Kim, Sang-Yoon, Lesur, Antoine, Sertamo, Katriina, Bernardin, François, Petritis, Konstantinos, Pirrotte, Patrick, Selinsky, Cheryl, Whiteaker, Jeffrey R., Zhang, Haizhen, Kennedy, Jacob J., Lin, Chenwei, Lee, Lik Wee, Yan, Ping, Tran, Nhan L., Inge, Landon J., Chalabi, Khaled, Decker, Georges, Bjerkvig, Rolf, Paulovich, Amanda G., Berchem, Guy, Kim, Yeoun Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352295/ https://www.ncbi.nlm.nih.gov/pubmed/32575471 http://dx.doi.org/10.3390/cancers12061629 |
Ejemplares similares
-
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer
por: El-Khoury, Victoria, et al.
Publicado: (2018) -
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
por: Bennett, Catherine W., et al.
Publicado: (2016) -
Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material
por: El-Khoury, Victoria, et al.
Publicado: (2016) -
Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma
por: Schritz, Anna, et al.
Publicado: (2021) -
High-Affinity Recombinant
Antibody Fragments (Fabs)
Can Be Applied in Peptide Enrichment Immuno-MRM Assays
por: Whiteaker, Jeffrey R., et al.
Publicado: (2014)